Correlation between Glycemic Control and Cardiovascular Events among Type-2 Diabetic Patients
DOI:
https://doi.org/10.54536/ajpehs.v3i2.5900Keywords:
Cardiovascular Events, Glycemic Control, HbA1c, Type-2 Diabetes MellitusAbstract
The aim of this study is to determine the relationship between cardiovascular events and glycemic management in Bangladeshi individuals with type 2 diabetes. A cross-sectional study. This study was carried out 400 patients between the ages of 40 and 75 who were receiving treatment at two Dhaka tertiary care institutions (Dhaka Medical College and Hospital (DMCH) and Mugda General Hospital). Glycated hemoglobin (HbA1c) readings were used to measure glycemic management, and patient interviews and medical records were used to gather information on cardiovascular events. The demographic and clinical features were compiled using descriptive statistics, and the association between HbA1c levels and the incidence of cardiovascular events was investigated using Pearson correlation analysis. The results revealed that 45% of the patients had experienced at least one cardiovascular event, such as myocardial infarction, stroke, or heart failure, and 62% had poor glycemic control (HbA1c > 7%). Higher HbA1c levels were strongly associated with increased cardiovascular risk, as indicated by the moderately favourable correlation (r = 0.39, p < 0.01) between HbA1c levels and cardiovascular events. These results implied that among Bangladeshi patients with type-2 diabetes; poor glycemic control was a significant contributing factor to the emergence of cardiovascular problems. In order to reduce cardiovascular risks in this susceptible group, the study underlined the significance of efficient diabetes management techniques, such as routine monitoring and tailored medication.
Downloads
References
Amna, G. (2024). The effect of glycemic control on cardiovascular disease progression in adults with early-onset type 2 diabetes: A longitudinal cohort analysis. Cureus. https://doi.org/10.7759/cureus.75058
Bao, S. (2021). Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications. Cardiovascular Diabetology, 20(1), 1–13. https://doi.org/10.1186/s12933-020-01200-7
Cavero-Redondo, I. (2017). Glycated haemoglobin A1c as a risk factor of cardiovascular outcomes and all-cause mortality in diabetic and non-diabetic populations: A systematic review and meta-analysis. BMJ Open, 7(7). https://doi.org/10.1136/bmjopen-2017-015949
Díaz-Flores, M. (2019, January 1). Biochemical mechanisms of vascular complications in diabetes. Springer, Cham. https://doi.org/10.1007/978-3-030-11815-0_45
Erdin, Z. (2023, December 31). Type 2 diabetes mellitus: Current diagnosis and treatment. SciSpace - Paper. https://doi.org/10.51271/jtpm-0053
Farzana, N. (2024). The pattern of diabetic care and glycemic control among the ambulatory diabetic patients in tertiary care settings in Bangladesh. Dental Science Reports, 14(1). https://doi.org/10.1038/s41598-024-67036-3
Gilani, A. (2024). The effect of glycemic control on cardiovascular disease progression in adults with early-onset type 2 diabetes: A longitudinal cohort analysis. Cureus. https://doi.org/10.7759/cureus.75058
Kranenburg, G. (2015). The relation between HbA1c and cardiovascular events in patients with type 2 diabetes with and without vascular disease. Diabetes Care, 38(10), 1930–1936. https://doi.org/10.2337/dc15-0493
Kim, J. H. (2021). Cardiovascular disease risk assessment in diabetes. The Journal of Korean Diabetes, 22(3), 168–173. https://doi.org/10.4093/jkd.2021.22.3.168
Latif, Z. A. (2017). A cross-sectional study to evaluate diabetes management, control and complications in patients with type 2 diabetes in Bangladesh. BIRDEM Medical Journal, 7(1), 17–27. https://doi.org/10.3329/birdem.v7i1.31268
Mak, K.-H. (2021). Prevalence of diabetes and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicities. European Journal of Preventive Cardiology. https://doi.org/10.1093/eurjpc/zwab011
Morris, E. (2023, September 18). The impact of inadequate glycemic control in type 2 diabetes mellitus patients at the diabetic clinic of Hoima Regional Referral Hospital in Hoima City. SciSpace - Paper. https://doi.org/10.59298/inosres/2023/2.7.1000
Mostafa, S. A. (2018). Modelling incremental benefits on complications rates when targeting lower HbA1c levels in people with type 2 diabetes and cardiovascular disease. Diabetic Medicine, 35(1), 72–77. https://doi.org/10.1111/dme.13533
Rana, J. (2024, October 30). Rising trends in diabetes and fasting plasma glucose among Bangladeshi adults: Insights from national surveys, 2011–2022. SciSpace - Paper; Cold Spring Harbor Laboratory. https://doi.org/10.1101/2024.10.30.24316405
Reza, H. M. (2021). Glycemic control and its associated factors among patients with diabetes mellitus: A cross-sectional study in Bangladesh. Nutrition & Food Science, 51(6), 936–946. https://doi.org/10.1108/nfs-09-2020-0343
Sara, S. S. (2023, January 1). Dynamic changes in prevalence of type 2 diabetes along with associated factors in Bangladesh: Evidence from two national cross-sectional surveys (BDHS 2011 and BDHS 2017–18). SciSpace - Paper. https://doi.org/10.1016/j.dsx.2023.102706
Shane, K. (2022). Prognostic significance of HbA1c level in Asian patients with prediabetes and coronary artery disease. Cardiovascular Innovations and Applications, 6(3). https://doi.org/10.15212/cvia.2021.0029
Sinha, B. (2021). A target HbA1c between 7 and 7.7% reduces microvascular and macrovascular events in T2D regardless of duration of diabetes: A meta-analysis of randomized controlled trials. Diabetes Therapy, 12(6), 1661–1676. https://doi.org/10.1007/s13300-021-01062-6
Sinha, B. C., & Sinha, B. C. (2021). Employee engagement, “myth or reality”?: A critical analysis of the entrepreneur and employee relationship in the recession phase of the business cycle. In IGI Global Scientific Publishing. https://doi.org/10.4018/978-1-7998-7951-0.ch008
Taylor, S. C. (2022). Understanding health outcomes and health equity. Journal of the American Academy of Dermatology, 87(6), 1277–1277. https://doi.org/10.1016/j.jaad.2022.11.006
Yeboah, J. (2018). Association between mean systolic blood pressure and cardiovascular outcomes in diabetes mellitus: ACCORD trial. Journal of Human Hypertension, 32(2), 167–169. https://doi.org/10.1038/s41371-017-0027-9
Yi, C. (2023). Cumulative HbA1c exposure as a CVD risk in patients with type 2 diabetes: A post hoc analysis of ACCORD trial. Diabetes Research and Clinical Practice, 111009. https://doi.org/10.1016/j.diabres.2023.111009
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Birupaksha Biswas, Umme Sadia, Md Sazzad Hossain, Sayonto Kumar Gomosta, Md Mehedi Hasan, Simonto Mirza
This work is licensed under a Creative Commons Attribution 4.0 International License.
